Gilead Sciences (GILD) Insider Trading & Ownership $92.58 +0.17 (+0.18%) (As of 11/29/2024 05:27 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Gilead Sciences (NASDAQ:GILD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.16%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$22.65 M Get GILD Insider Trade Alerts Want to know when executives and insiders are buying or selling Gilead Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GILD Insider Buying and Selling by Quarter Ad Chaikin AnalyticsIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is making headlines for last week's new earnings report – which revealed the AI juggernaut nearly doubled their profits in the last year alone.A 50-year Wall Street veteran gives his answer Nvidia, right here... Gilead Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/27/2024Merdad ParseyInsiderSell164,211$91.92$15,094,275.12 11/26/2024Jeffrey BluestoneDirectorSell6,788$91.39$620,355.32 11/6/2024Merdad ParseyInsiderSell25,590$91.50$2,341,485.00 10/1/2024Merdad ParseyInsiderSell2,000$83.83$167,660.00 9/12/2024Johanna MercierInsiderSell29,357$83.78$2,459,529.46 8/13/2024Johanna MercierInsiderSell5,490$73.98$406,150.20 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/1/2024Merdad ParseyInsiderSell2,000$68.63$137,260.00 5/10/2024Tommy TubervilleU.S. Congress Member (R-AL)Buy$65.96$1,001 - $15,0005/8/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$64.92$1,001 - $15,0004/5/2024Tommy TubervilleU.S. Congress Member (R-AL)Buy$69.58$1,001 - $15,0004/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$70.89$1,001 - $15,0004/1/2024Merdad ParseyInsiderSell2,000$72.96$145,920.00 2/28/2024Merdad ParseyInsiderSell2,000$73.18$146,360.00 1/16/2024Andrew D DickinsonCFOSell5,000$85.78$428,900.00 1/9/2024Johanna MercierInsiderSell8,242$85.23$702,465.66 (Data available from 1/1/2013 forward) GILD Insider Trading Activity - Frequently Asked Questions Who is on Gilead Sciences's Insider Roster? The list of insiders at Gilead Sciences includes Andrew D Dickinson, Brett A Pletcher, Diane E Wilfong, Jeffrey Bluestone, Johanna Mercier, and Merdad Parsey. Learn more on insiders at GILD. What percentage of Gilead Sciences stock is owned by insiders? 0.16% of Gilead Sciences stock is owned by insiders. Learn more on GILD's insider holdings. Which Gilead Sciences insiders have been selling company stock? The following insiders have sold GILD shares in the last 24 months: Andrew D Dickinson ($1,228,900.00), Jeffrey Bluestone ($620,355.32), Johanna Mercier ($3,568,145.32), and Merdad Parsey ($19,784,811.99). How much insider selling is happening at Gilead Sciences? Insiders have sold a total of 284,774 Gilead Sciences shares in the last 24 months for a total of $25,202,212.63 sold. Which members of congress are trading Gilead Sciences? Tommy Tuberville (R-AL) has bought shares of Gilead Sciences in the last year totaling $16,000. Tommy Tuberville (R-AL) has sold shares totaling $16,000. Gilead Sciences Key ExecutivesMr. Daniel P. O'Day (Age 60)Chairman & CEO Compensation: $6.99MMr. Andrew D. Dickinson (Age 54)Chief Financial Officer Compensation: $2.66MMs. Deborah H. Telman (Age 59)Executive VP of Corporate Affairs, General Counsel & Corporate Secretary Compensation: $2.56MMs. Johanna Mercier (Age 54)Chief Commercial Officer Compensation: $3.1M2 recent tradesDr. Merdad V. Parsey M.D. (Age 60)Ph.D., Chief Medical Officer Compensation: $2.79MMs. Sandra Patterson (Age 57)Senior VP, Corporate Controller & Principal Accounting Officer Ms. Jacquie Ross C.F.A.Vice President of Investor RelationsMs. Jyoti K. Mehra (Age 48)Executive Vice President of Human Resources Dr. Linda Slanec Higgins Ph.D. (Age 62)Senior Vice President of Research, Innovation & Portfolio Dr. Rudolf Ertl (Age 78)Senior Vice President of Commercial Operations of Australia, Canada, Europe More Insider Trading Tools from MarketBeat Related Companies AMGN Insider Buying VRTX Insider Buying REGN Insider Buying ALNY Insider Buying BIIB Insider Buying UTHR Insider Buying INCY Insider Buying NBIX Insider Buying BMRN Insider Buying EXEL Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024?Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in Buybacks This page (NASDAQ:GILD) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored***TODAY ONLY*** Is this Trump’s Favorite Coin?Donald Trump just emphatically became America's first crypto president. Trump plans to make America, "the...Weiss Ratings | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GILD Stock Alerts